November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Scientists Catalog Thousands of Potential Biomarkers for Inflammatory Bowel Disease

🧠 AI Analysis 2 min read 👁 6

Researchers have identified nearly 10,000 biological markers that could help track disease severity and medication response in patients with Crohn’s and colitis.

🧠AI Analysis

Key points

  • Researchers identified over 9,000 potential biomarkers for IBD severity and treatment response.
  • The study utilized multiomics data from the SPARC IBD cohort across the United States.
  • Findings aim to address low response rates and side effects in current Crohn's and colitis treatments.

Researchers have compiled a massive catalog of biological markers that may help track the progression and treatment response of inflammatory bowel disease (IBD). The study, conducted by scientists at Enveda Therapeutics, utilized a large multiomics dataset to identify nearly 10,000 potential indicators related to disease severity and medication efficacy.

Mapping Molecular Signatures

Using data from the Study of a Prospective Adult Research Cohort (SPARC IBD), the team analyzed transcriptomics and proteomics to find signatures across different tissues and diagnoses. They identified 9,678 biomarkers linked to disease severity, 299 associated with specific medication use, and 59 that may predict how a patient responds to therapy. These findings cover both Crohn’s disease and ulcerative colitis, offering a more granular look at how these conditions manifest at a molecular level.

While the catalog is extensive, the researchers emphasize that these signatures are currently intended to generate new hypotheses rather than serve as immediate diagnostic tools. The study notes that current IBD treatments often suffer from low response rates and significant side effects, making better tracking tools a priority. However, before these biomarkers can be used to guide patient care, they must undergo further validation through long-term prospective studies.

The data was sourced from the Crohn’s & Colitis Foundation’s IBD Plexus platform, which integrates electronic health records with biological samples like blood and stool from patients across the United States. What to know: This research is in its early stages and does not change current treatment protocols. Patients should always consult their healthcare provider before making changes to their medication or management plan.

Source Nature Health Sciences — nature.com/articles/s41598-026-80167-z ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.